Nexlizet (bempedoic acid/ezetimibe) is a prescription tablet used to help lower cholesterol and reduce the risk of heart attack as well as heart surgery. Nexlizet is prescribed for certain adults ...

Nexletol (bempedoic acid) is a prescription ... Nexletol comes as an oral tablet that you swallow. For reducing LDL cholesterol, Nexletol is used either alone or with other cholesterol-lowering ...

to expand the use of its prescription medicines NEXLETOL ® (bempedoic acid) Tablets and NEXLIZET ® (bempedoic acid and ezetimibe) Tablets, which are currently approved, along with diet and other ...

That document listed bempedoic acid and bempedoic acid/ezetimibe as nonstatin therapies that may be used to manage atherosclerotic ... statin therapy) is one tablet of 180 mg once per day, taken ...

The FDA approved label expansions for bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet) so they can be used more broadly ... taken as once-daily oral tablets.

If patients could not receive placebo because of unacceptable adverse effects or if adherence was less than 80% according to the tablet count ... support the use of bempedoic acid as an ...

These approvals also eliminate the statin use requirement ... of the CLEAR clinical research program for NEXLETOL ® (bempedoic acid) Tablet and NEXLIZET ® (bempedoic acid and ezetimibe) Tablet.

Bempedoic acid uses the same biological pathway as statins do, but isn't activated until it gets to the liver, which may be why it doesn't have the same side effects on muscle, the brain and other ...

said that providers are already prescribing bempedoic acid for some patients, but with this new research, he thinks they will quickly be used with more statin-intolerant patients. “We continue ...

Esperion Therapeutics (NASDAQ:ESPR) shares gained 7% premarket on Monday after the company touted clinical benefits of NEXLETOL (bempedoic acid) tablets in diverse populations, including women ...

The use of bempedoic acid (Nexletol; Esperion) safely lowers LDL cholesterol levels and reduces cardiovascular events in statin-intolerant patients with and without diabetes, according to results of a ...

Opens in a new tab or window SAN DIEGO -- Bempedoic acid (Nexletol ... treatment among patients who are unable or unwilling to use statins in the real world. "Let me tell you what the bottom ...